HIV Surveillance Update
|
|
|
- Gerard Hopkins
- 10 years ago
- Views:
Transcription
1 HIV Surveillance Update Presentation to: CAPUS Metro Atlanta Testing and Linking Consortium (MATLC) Presented by: Deepali Rane, MPH and Jane Kelly, MD Georgia Department of Public Health Epidemiology Date: July 22, 2013
2 Overview Prevalence maps Demographic profile of HIV in Georgia Care Cascade methodology Atlanta EMA Care Cascade Future Plans for HIV Surveillance Data for Decision-Making
3
4 Rates of Persons Living with an HIV Diagnosis, by County, Georgia, 2010 * Data are not shown to protect privacy. ** State health department requested not to release data. Note. Data include persons with a diagnosis of HIV infection, regardless of the stage of disease at diagnosis, and have been statistically adjusted to account for reporting delays and missing risk-factor information, but not for incomplete reporting. Data Source: Centers for Disease Control and Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Division of HIV/AIDS Prevention.
5 Persons Living with an HIV or AIDS Diagnosis, by ZIP Code Atlanta, GA 2013 Update
6 Rates of Persons Living with an HIV or AIDS Diagnosis, by ZIP Code, Atlanta, 2010 * Data are not shown to protect privacy because of a small number of cases and/or a small population size. Notes. Rates include persons living with an HIV or AIDS diagnosis in Clayton, Cobb, DeKalb, Fulton, and Gwinnett Counties at the end of 2010 and who were reported as of 04/01/2013. Data have not been adjusted for reporting delays. Data Source: Georgia Department of Public Health, Division of Health Protection, Epidemiology Program, HIV/AIDS Epidemiology Section.
7 Rates of Black & White Persons Living with an HIV or AIDS Diagnosis, by ZIP Code, Atlanta, 2010 Black Rates White Rates * Data are not shown to protect privacy because of a small number of cases and/or a small population size.
8 Rates of Persons Aged Living with an HIV or AIDS Diagnosis, by ZIP Code, Atlanta, 2010 * Data are not shown to protect privacy because of a small number of cases and/or a small population size.
9 Rates of Persons Living with an HIV Diagnosis & Poverty Rates, by ZIP Code, Atlanta, 2010 Persons Living with an HIV Diagnosis Poverty Rates * Data are not shown to protect privacy because of a small number of cases and/or a small population size. Data not available because the data source does not publish these data for this jurisdiction.
10 Cumulative cases of HIV infection among persons aged 13 and older diagnosed in Georgia and Metro Atlanta* by year Year of diagnosis Male (GA) Male (Metro Atl) Female (GA) Female (Metro Atl) Sex not reported (GA) Sex not reported (Metro Atl) ,510 25,271 10,447 5, ,939 26,719 11,248 6, ,286 28,086 12,056 6, ,454 29,412 12,739 6, ,533 30,899 13,443 7, Includes HIV infection (not AIDS) and AIDS Includes persons living and deceased *Metro-Atlanta (Metro Atl) includes Fulton, DeKalb, Cobb/Douglas, Gwinnett and Clayton counties
11 Cumulative cases of AIDS among persons aged 13 and older diagnosed in Georgia and Metro Atlanta by year Year of diagnosis Male (GA) Male (Metro Atl) Female (GA) Female (Metro Atl) Sex not reported (GA) Sex not reported (Metro Atl) ,836 18,402 6,350 3, ,809 19,361 6,680 3, ,785 20,236 7,050 4, ,610 20,957 7,303 4, ,362 21,664 7,544 4, Includes AIDS only Includes persons living and deceased
12 HIV diagnoses among persons aged 13 and older, Georgia and Metro Atlanta, Year of diagnosis HIV infection No. (GA) ,757 2, ,617 1, ,755 1, ,320 2, ,222 1, ,935 1, ,804 1, ,006 1, ,893 1,698 Includes HIV infection (not AIDS) and AIDS HIV Infection No. (Metro Atl)
13 Adults and adolescents living with HIV, by sex, Georgia and Metro Atlanta, 2011 Georgia Metro Atlanta Adults >= age 13, diagnosed by12/31/2010, living as of 12/31/2011, Georgia = 41,934, Metro Atlanta=23,037
14 Males living with HIV by race/ethnicity, Georgia and Metro Atlanta,2011 Georgia Metro Atlanta Adults >= age 13, diagnosed by12/31/2010, living as of 12/31/2011, Georgia = 30,696, Metro Atlanta= 18,089
15 Females living with HIV by race/ethnicity, Georgia and Metro Atlanta,2011 Georgia Metro Atlanta Adults >= age 13, diagnosed by12/31/2010, living as of 12/31/2011, Georgia = 10,576, Metro Atlanta=4809
16 Males living with HIV by transmission category, Georgia and Metro Atlanta 2011 Georgia Metro Atlanta Adults >= age 13, diagnosed by12/31/2010, living as of 12/31/2011, Georgia = 30,696, Metro Atlanta=18,089 MSM = Male to male sexual contact IDU = Injection drug use MSM/IDU = Male to male sexual contact and injection drug use Heterosexual contact with a person known to have, or to be at high risk for, HIV infection. Other = hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified
17 Females living with HIV by transmission category, Georgia and Metro Atlanta, 2011 Georgia Metro Atlanta Adults >= age 13, diagnosed by12/31/2010, living as of 12/31/2011, Georgia = 10,576, Metro Atlanta=4,809 IDU = Injection drug use Heterosexual contact with a person known to have, or to be at high risk for, HIV infection. Other =hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified
18 Adults and adolescents living with HIV by age at diagnosis, Georgia and Metro Atlanta % 33% 33% 30% 28% 28% 25% 20% 15% 18% 18% 16% 16% Georgia Metro Atlanta 10% 5% 6% 5% 0% Adults >= age 13, diagnosed by12/31/2010, living as of 12/31/2011, Georgia = 41,934, Metro Atlanta= 23,037
19 Preliminary data: As of June, 2013 the number of people diagnosed as living with HIV in Georgia is ~50,000
20 Persons with HIV Engaged in Selected Stages of the Continuum of Care, United States Percent Hall et al. XIX International AIDS Conference, 2012 ART, antiretroviral therapy
21 Care Cascade Methodology, 2011, Atlanta EMA* Adults and adolescents are those aged >= 13 years Diagnosed between 01/01/11-12/31/11 Current address Atlanta Eligible Metropolitan Service Area (EMA) Linked to care = CD4 or VL within 3 months of diagnosis, excluding day of diagnosis Engaged in care >= 1 CD4 or VL 4-15 months after diagnosis Retained in care >= 2 CD4 or VL at least 3 months apart 4-15 months after diagnosis Estimated prescribed ART derived from MMP sample Viral suppression (VS) = VL<200 copies/ml most recent viral load All percentages are % of total number of persons diagnosed with HIV *EMA: Bartow, Paulding, Carroll, Coweta, Fayette, Spalding, Henry, Newton, Rockdale, Gwinnett, Walton, Barrow, Forsyth, Cherokee, Pickens, DeKalb, Fulton, Clayton, Cobb and Douglas counties.
22 Care Cascade Methodology Months 0-3 after diagnosis Months 4-15 after diagnosis Confirmatory Diagnosis Date CD4 or Viral Load This person is: Linked YES Engaged YES Retained YES Virally suppressed YES CD4 or Viral Load CD4 or Viral Load Last viral load <200 copies/ml
23 Care Cascade Methodology Months 0-3 after diagnosis Months 4-15 after diagnosis Confirmatory Diagnosis Date CD4 or Viral Load CD4 or Viral Load Last viral load undetectable This person is Linked YES Engaged YES Retained NO Virally suppressed YES Engaged in care is minimal engagement that indicates the person touched the medical system at least once during that 12 month period
24 Care Cascade Methodology Months 0-3 after diagnosis Months 4-15 after diagnosis Confirmatory Diagnosis Date CD4 or Viral Load CD4 done but no viral load done This person is Linked NO Engaged YES Retained YES Virally suppressed NO If no viral load done, it is assumed to be not suppressed
25 Adults and adolescents diagnosed with HIV infection, Atlanta EMA, 2011 Adults and adolescents >= age 13, diagnosed 01/01/11-12/31/11, current address Atlanta EMA = 1949 Linked to care = CD4 or VL within 3 months of diagnosis Engaged in care >= 1 CD4 or VL 4-15 months after diagnosis Retained in care >= 2 CD4 or VL at least 3 months apart 4-15 months after diagnosis Viral suppression (VS) = VL<200 copies/ml in most recent viral load = 596 Note: all percentages are proportion of total number of persons diagnosed with HIV in category
26 Adults and adolescents diagnosed with HIV infection, by race, Atlanta EMA 2011 Adults and adolescents >= age 13, diagnosed 01/01/11-12/31/11, Atlanta EMA = 1949 *American Indian/Alaska Native, Asian, and Native Hawaiian/Other Pacific Islanders combined equal <1% of new diagnoses and are included in Other/Unknown
27 Transmission category definitions MSM = Male to male sexual contact IDU = Injection drug use MSM/IDU = Male to male sexual contact and injection drug use HET = Heterosexual contact with a person known to have, or to be at high risk for, HIV infection Other = hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified Multiple imputation was used to re-distribute transmission category where missing
28 Adults and adolescents diagnosed with HIV infection, by transmission category*, Atlanta EMA, 2011 N=979 N=92 N=26 N=294 N=558 Adults and adolescents >= age 13, diagnosed 01/01/11-12/31011, Atlanta EMA = 1949 *Multiple imputation was used to re-distribute transmission category where missing
29 Adult and adolescent males diagnosed with HIV infection, by transmission category*, Atlanta EMA, 2011 Adult and adolescent males >= age 13, diagnosed 01/01/11-12/31/11, Atlanta EMA *Multiple imputation was used to re-distribute transmission category where missing
30 Adults and adolescent females diagnosed with HIV infection, by transmission category*, Atlanta EMA, 2011 N=48 N=234 N=92 Adults and adolescent females >= age 13, diagnosed 01/01/11-12/31/11, Atlanta EMA = 374 *Multiple imputation was used to re-distribute transmission category where missing
31 Adults and adolescents diagnosed with HIV infection, by age, Atlanta EMA, 2011 N=422 N=566 N=447 N=356 N=158 Adults and adolescents >= age 13, diagnosed 01/01/11-12/31011, current address Atlanta EMA = 1949 Note: all percentages are proportion of total number of persons diagnosed with HIV in category
32 Young Black MSM diagnosed with HIV infection, by age, Fulton/DeKalb Counties, 2010 Adults >= age 13, diagnosed between 1/1/2010 and 12/31/2010, living as of 12/31/2011 Address at diagnosis in Fulton and DeKalb counties
33 ART Use and Viral Suppression Among HIV-Infected Patients in Care Cross-sectional study at seven sites in the Centers for AIDS Research Network of Integrated Clinical Systems cohort Of 8633 patients with 1 medical visit and 1 measured viral load in 2010, 89% were taking ART, and 79% had viral loads 200 copies/ml Lower rates of VS among women, age <50, Blacks, and patients not engaged in continuous care Engagement in care was the factor most strongly associated with ART use and viral suppression, after adjustment for nadir CD4 count Reference: Dombrowski JC et al. High levels of antiretroviral use and viral suppression among persons in HIV care in the United States, J Acquir Immune Defic Syndr 2013 Jul 1; 63:299.
34 Viral suppression (VS) among adults and adolescents living with HIV and retained in care, by sex, Georgia 2011 Adults >= age 13, diagnosed by12/31/2010, living as of 12/31/2011, Georgia = 41,934
35 Viral suppression (VS) among adults and adolescents living with HIV and retained in care, by transmission category, Georgia 2011 Adults >= age 13, diagnosed by12/31/2010, living as of 12/31/2011, Georgia = 41,934
36 Viral suppression (VS) among adults and adolescents living with HIV and retained in care, by age, Georgia 2011 Adults >= age 13, diagnosed by12/31/2010, living as of 12/31/2011, Georgia = 41,934
37 Viral suppression (VS) among adults and adolescents living with HIV and engaged in care, by race/ethnicity, Georgia 2011
38 Care Cascades can help us Focus our efforts for linkage, retention and viral suppression Identify groups at increased risk for dropping out of each step in the cascade Monitor our progress in improvement Identify disparities not only in prevalence but in care Evaluate efforts addressing specific populations Follow efforts in specific counties, census tracts, zip codes and some specific facilities Improve surveillance completeness (race, sex, transmission category)
39 Stage of HIV disease at diagnosis Stage at diagnosis is defined by the first CD4 done within 3 months of diagnosis Stage 1 = CD4 >=500 Stage 2 = CD Stage 3 = CD4 <200 or OI Stage at diagnosis is unknown if no CD4 done within 3 months of diagnosis
40 Stage of disease by earliest CD4 count within 3 months of HIV diagnosis, adults and adolescents, Atlanta EMA, 2011 Adults and adolescents >= age 13, diagnosed 1/1/ /31/2011, Atlanta EMA = 1949 CD4<200 = Stage 3 disease (AIDS) Stage unknown = no CD4 within 3 months of diagnosis
41 Stage of disease by earliest CD4 count within 12 months of HIV diagnosis, adults and adolescents, Georgia 2011 Adults and adolescents >= age 13, diagnosed 1/1/ /31/2011, Atlanta EMA = 1949 CD4<200 = Stage 3 disease (AIDS) Stage unknown = no CD4 within 12 months of diagnosis
42 Stage of disease by CD4 count within 12 months of HIV diagnosis, adults and adolescents, by sex, Atlanta EMA, 2011 Adults and adolescents >= age 13, diagnosed 1/1/ /31/2011, Atlanta EMA = 1949 CD4<200 = Stage 3 disease (AIDS) Stage Unknown = no CD4 within 12 months of diagnosis Excludes 12 cases for which sex was not reported
43 Stage of disease by earliest CD4 count within 12 months of HIV diagnosis, adults and adolescents, by age (years), Atlanta EMA, 2011 Adults and adolescents >= age 13, diagnosed 1/1/ /31/2011, Atlanta EMA = 1949 CD4<200 = Stage 3 disease (AIDS) Stage Unknown = no CD4 within 3 months of diagnosis
44 Stage of disease by CD4 count within 12 months of HIV diagnosis, adults and adolescents, by race/ethnicity, Atlanta EMA, 2011 Adults >= age 13, diagnosed 1/1/ /31/2011, Atlanta EMA = 1949 CD4<200 = Stage 3 disease (AIDS) Stage Unknown = no CD4 within 3 months of diagnosis *American Indian/Alaska Native, Asian and Native Hawaiian/Pacific Islander groups together constitute <1% of adults diagnosed with HIV in Georgia, 2010 and are grouped with other/unknown race/ethnicity
45 Stage of disease by earliest CD4 count within 12 months of HIV diagnosis, adults and adolescents, by transmission category*, Atlanta EMA, 2011 Adults and adolescents >= age 13, diagnosed 1/1/ /31/2011, Atlanta EMA = 1949 CD4<200 = Stage 3 disease (AIDS) Stage Unknown = no CD4 within12 months of diagnosis *Multiple imputation was used to re-distribute transmission category where missing
46 Stage of disease (earliest CD4) at or within 12 months of diagnosis can help us Quantify late diagnoses Evaluate screening initiatives Identify disparities Monitor trends in earlier diagnosis Assess outreach and screening efforts Follow trends Triage into appropriate care
47 Incomplete reporting Limitations Definition of heterosexual transmission (sexual contact with a known HIV infected partner or person with increased risk, i.e., MSM or IDU) Lack of transmission category information Missing data for race/ethnicity, sex, transmission category, and address at diagnosis Missing laboratory reports CD4 within 3 months of diagnosis yields high unknown stage in Georgia
48 Uncertainties Populations for which data are missing may be fundamentally different How to obtain data for transsexual category How to improve completeness of reporting Data on ART use Understanding barriers to ART adherence
49 Questions? Contact information: Jane Kelly Georgia Department of Public Health HIV/AIDS Epidemiology Section 2 Peachtree St Atlanta GA [email protected] (office)
Using HIV Surveillance Data to Calculate Measures for the Continuum of HIV Care
Using HIV Surveillance Data to Calculate Measures for the Continuum of HIV Care Anna Satcher Johnson, MPH Symposium on Measuring the HIV Care Continuum Center for AIDS Research University of Washington
Understanding the HIV Care Continuum
Understanding the HIV Care Continuum Overview Recent scientific advances have shown that antiretroviral therapy (ART) not only preserves the health of people living with HIV, but also dramatically lowers
HIV Epidemiology in New York State
HIV Epidemiology in New York State Lou Smith, MD, MPH Director, Division of Epidemiology, Evaluation and Research AIDS Institute, New York State Department of Health 2 HIV Surveillance in New York State
Estimates of New HIV Infections in the United States
Estimates of New HIV Infections in the United States Accurately tracking the HIV epidemic is essential to the nation s HIV prevention efforts. Yet monitoring trends in new HIV infections has historically
45-64 AGE GROUP IS FASTEST GROWING SEGMENT
The Graying of Atlanta: A Look at the Latest 2010 Census Data September 2011 Recently-released data from the 2010 Census reveal that the Atlanta region is getting older and that those ages 45-64 make up
Illustrating HIV/AIDS in the United States
Illustrating HIV/AIDS in the United States Black Persons 2013 Update About AIDSVu AIDSVu is a compilation of interactive, online maps that allows users to visually explore the HIV epidemic in the U.S.
EXECUTIVE SUMMARY: INTEGRATED EPIDEMIOLOGIC PROFILE FOR HIV/AIDS PREVENTION AND CARE ELIGIBLE METROPOLITAN AREA PLANNING, PHILADELPHIA
EXECUTIVE SUMMARY: INTEGRATED EPIDEMIOLOGIC PROFILE FOR HIV/AIDS PREVENTION AND CARE PLANNING, PHILADELPHIA ELIGIBLE METROPOLITAN AREA 2015 Prepared for the Philadelphia Eligible Metropolitan Area Ryan
2015 Outline of Medicare Supplement Coverage Cover Page (1 of 2) Plans A, F & N
BlueCross BlueShield of Georgia Administrative Office: P.O. Box 9063, Oxnard, CA 93031-9063 Toll Free Telephone Number: 1-888-211-9817 2015 Outline of Medicare Supplement Coverage Cover Page (1 of 2) Plans
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Age Differences in Viral Suppression, Antiretroviral Therapy Use, and Adherence Among HIV-positive Men Who Have Sex With Men Receiving
Injection Drug Users in Miami-Dade: NHBS-IDU2 Cycle Preliminary Results
Injection Drug Users in Miami-Dade: NHBS-IDU2 Cycle Preliminary Results David W. Forrest, Ph.D. Marlene LaLota, M.P.H. John-Mark Schacht Gabriel A. Cardenas, M.P.H. Lisa Metsch, Ph.D. National HIV Behavioral
2012 2014 Maryland HIV Plan
Maryland Department of Health & Mental Hygiene Prevention and Health Promotion Administration 2012 2014 Maryland HIV Plan Comprehensive HIV Plan Statewide Coordinated Statement of Need Maryland HIV Prevention
HIV/AIDS in the Houston Area
HIV/AIDS in the Houston Area The 2013 Houston Area Integrated Epidemiologic Profile for HIV/AIDS Prevention and Care Services Planning Page 1 Disclaimer: This document is the most current HIV/AIDS epidemiologic
Hepatitis C Virus Infection: Prevalence Report, 2003 Data Source: Minnesota Department of Health HCV Surveillance System
Hepatitis C Virus Infection: Prevalence Report, 2003 Data Source: Minnesota Department of Health HCV Surveillance System P.O. Box 9441 Minneapolis, MN 55440-9441 612-676-5414, 1-877-676-5414 www.health.state.mn.us/immunize
THE NAIS DEMOGRAPHIC CENTER Metropolitan Area Reports
THE NAIS DEMOGRAPHIC CENTER Metropolitan Area Reports CBSA 1 : Atlanta-Sandy Springs-Marietta, GA 2 Metropolitan Area Reports summarize key demographic changes for a specific geographic region, suggest
Minnesota HIV/AIDS Epidemiologic Profile
Minnesota HIV/AIDS Epidemiologic Profile DECEMBER 2015 Executive Summary Abbreviations Used AIDS Acquired Immune Deficiency Syndrome ADAP AIDS Drugs Assistance Program CCCHAP Community Cooperative Council
Integrating Medical Care Coordination Services into HIV Clinic Medical Homes
Integrating Medical Care Coordination Services into HIV Clinic Medical Homes Carlos Vega-Matos, M.P.A. HIV Care Services Division Division of HIV and STD Programs Background DHSP funds HIV Clinics to provide
Case Finding for Hepatitis B and Hepatitis C
Case Finding for Hepatitis B and Hepatitis C John W. Ward, M.D. Division of Viral Hepatitis Centers for Disease Control and Prevention Atlanta, Georgia, USA Division of Viral Hepatitis National Center
HIV/AIDS Epidemiology Report
HIV/AIDS Epidemiology Report 2012 County of San Diego Health and Human Services Agency Division of Public Health Services Epidemiology and Immunization Services Branch HIV/AIDS Surveillance Program Epidemiology
Targeted HIV Testing & Enhanced Testing Technologies. HIV Prevention Section Bureau of HIV/AIDS
Targeted HIV Testing & Enhanced Testing Technologies HIV Prevention Section Bureau of HIV/AIDS May 2012 1 Typing a Question in the Chat Box Type question in here 2 Completing the Webinar Evaluation (opened
Correlates of not receiving HIV care among HIV-infected women enrolling in a HRSA SPNS multi-site initiative
Correlates of not receiving HIV care among HIV-infected women enrolling in a HRSA SPNS multi-site initiative Oni J. Blackstock, MD, MHS Assistant Professor of Medicine Division of General Internal Medicine
The HIV/AIDS Epidemic in California s Latino Population
The HIV/AIDS Epidemic in California s Latino Population Barbara Bailey, M.S. Acting Chief Office of AIDS California Department of Health Services www.dhs.ca.gov/aids AIDS Incidence (Cases per 100,000)
HIV Continuum of Care Monitoring Framework 2014
HIV Continuum of Care Monitoring Framework 2014 Addendum to meeting report: Regional consultation on HIV epidemiologic information in Latin America and the Caribbean HIV Continuum of Care Monitoring Framework
SUBSTANCE ABUSE TREATMENT NEEDS ASSESSMENT AND RESOURCE INVENTORY FOR PEOPLE LIVING WITH HIV DISEASE IN THE ATLANTA EMA
SUBSTANCE ABUSE TREATMENT NEEDS ASSESSMENT AND RESOURCE INVENTORY FOR PEOPLE LIVING WITH HIV DISEASE IN THE ATLANTA EMA July, 2002 Prepared for: Fulton County Government Metropolitan Atlanta HIV Health
Healthy People 2020: Who s Leading the Leading Health Indicators?
Healthy People 2020: Who s Leading the Leading Health Indicators? Don Wright, MD, MPH Deputy Assistant Secretary for Health Promotion and Disease Prevention Who s Leading the Leading Health Indicators?
Paulding County School District 2015 BENEFITS OPEN ENROLLMENT REVIEW
Paulding County School District 2015 BENEFITS OPEN ENROLLMENT REVIEW 1 ShawHankins Service Center- can answer questions on all benefits, including state health Available extended hours 8:30 am 7:00 pm
Atlanta Journal-Constitution
A Division of Bankrate, Inc. Reach 1,000,000+ Georgia Readers Atlanta Journal-Constitution Mortgage Guide Mortgage Guide About Bankrate Print: Offers flexibility to market your mortgage products on a local,
Fulton County Department of Health and Wellness High Impact HIV Prevention Program
Fulton County Department of Health and Wellness High Impact HIV Prevention Program City of Atlanta (Fulton/DeKalb Counties) Jurisdictional HIV Prevention Plan November 14, 2012 December 31, The City of
HPTN 073: Black MSM Open-Label PrEP Demonstration Project
HPTN 073: Black MSM Open-Label PrEP Demonstration Project Overview HIV Epidemiology in the U.S. Overview of PrEP Overview of HPTN HPTN 061 HPTN 073 ARV Drug Resistance Conclusions Questions and Answers
Six-Month Outcomes from a Medical Care Coordination Program at Safety Net HIV Clinics in Los Angeles County (LAC)
Six-Month Outcomes from a Medical Care Coordination Program at Safety Net HIV Clinics in Los Angeles County (LAC) Wendy H. Garland, MPH; Rhodri Dierst- Davies, MPH; Sonali P. Kulkarni, MD, MPH 9 th International
Impact of Diabetes on Treatment Outcomes among Maryland Tuberculosis Cases, 2004-2005. Tania Tang PHASE Symposium May 12, 2007
Impact of Diabetes on Treatment Outcomes among Maryland Tuberculosis Cases, 2004-2005 Tania Tang PHASE Symposium May 12, 2007 Presentation Outline Background Research Questions Methods Results Discussion
Outpatient/Ambulatory Health Services
Outpatient/Ambulatory Health Services Service Definition Outpatient/ambulatory medical care includes the provision of professional diagnostic and therapeutic services rendered by a physician, physician
2014-2016 ALAMEDA COUNTY, CALIFORNIA COMPREHENSIVE HIV PREVENTION PLAN
2014-2016 ALAMEDA COUNTY, CALIFORNIA COMPREHENSIVE HIV PREVENTION PLAN JULY 2014 Prepared by the Oakland TGA Collaborative Community Planning Council HIV Prevention Committee & the Alameda County Office
Drug Abuse Trends in the Seattle/King County Area: 2013
Drug Abuse Trends in the Seattle/King County Area: 2013 Caleb Banta-Green, 1 T. Ron Jackson, 2 Steve Freng, 3 Michael Hanrahan, 4 Cynthia Graff, 5 John Ohta, 6 Mary Taylor, 7 Richard Harruff, 8 Robyn Smith,
EXPANDED HIV TESTING AND LINKAGE TO CARE (X-TLC) IN HEALTHCARE SETTINGS ON THE SOUTH SIDE OF CHICAGO
EXPANDED HIV TESTING AND LINKAGE TO CARE (X-TLC) IN HEALTHCARE SETTINGS ON THE SOUTH SIDE OF CHICAGO R Eavou, M Taylor, C Bertozzi-Villa, D Amarathithada, R Buffington, D Pitrak and N Benbow HIV Prevention
CHURCHES HOMES FOUNDATION, INC.
CHURCHES HOMES FOUNDATION, INC. GENERAL GUIDELINES FOR SUBMITTING SCHOLARSHIP APPLICATIONS The Churches Homes Foundation is committed to promoting access to post-secondary education for students in the
Educational Attainment of Veterans: 2000 to 2009
Educational Attainment of Veterans: to 9 January 11 NCVAS National Center for Veterans Analysis and Statistics Data Source and Methods Data for this analysis come from years of the Current Population Survey
Public Health Management Corporation. Address: Street City Zip Code. Medical Case Manager /Housing Counselor. Email:
APPLICATION COVER PAGE Agency: Address: Street City Zip Code Medical Case Manager /Housing Counselor Phone: (Print Name) Email: I attest the information and documentation submitted is accurate and verified
TUBERCULOSIS (TB) SCREENING GUIDELINES FOR RESIDENTIAL FACILITIES AND DRUG
TUBERCULOSIS (TB) SCREENING GUIDELINES FOR RESIDENTIAL FACILITIES AND DRUG Tx CENTERS Tuberculosis Control Program Health and Human Services Agency San Diego County INTRODUCTION Reducing TB disease requires
2013 STD/HIV Surveillance Report
213 STD/HIV Surveillance Report State of Louisiana Department of Health and Hospitals Office of Public Health Louisiana Department of Health and Hospitals Office of Public Health STD/HIV Program 145 Poydras
Richard H. Needle, PhD, MPH Lin Zhao, PhD candidate (UCSF School of Nursing) CSIS Africa Program Roundtable June 10, 2010
Richard H. Needle, PhD, MPH Lin Zhao, PhD candidate (UCSF School of Nursing) CSIS Africa Program Roundtable June 10, 2010 Reference Group to the United Nations on HIV and Injecting Drug Use 2010 Mathers:
The Ryan White CARE Act 2000 Reauthorization
POLICY BRIEF january 2001 The Ryan White CARE Act 2000 Reauthorization Overview As the Ryan White CARE Act enters its second decade, it continues to be a critical source of care and services for people
Quality Management Plan
Quality Management Plan West Palm Beach Eligible Metropolitan Area 2015-2018 Revised April 2015 Page 1 QUALITY MANAGEMENT PLAN West Palm Beach EMA Prepared by: Shoshana Ringer, Quality Management Coordinator
Epidemiologic Profile for HIV/STD Prevention & Care Planning
Epidemiologic Profile for HIV/STD Prevention & Care Planning December 2012 Please direct any comments or questions to: Communicable Disease Surveillance Unit North Carolina Communicable Disease Branch
Blood & Marrow Transplant Group of Georgia Patient Demographic Form PLEASE FILL OUT FRONT AND BACK OF THIS FORM
Blood & Marrow Transplant Group of Georgia Patient Demographic Form ***Please complete entire form---do not leave any blanks*** BLOOD MARROW TRANSPLANT GROUP OF GEORGIA DEMOGRAPHIC FORM H. Kent Holland,
Program Performance Indicators Revised Baseline & Target Setting Form January 1 June 30, 2004 Interim Progress Report
ATTACHMENT B Program Performance Indicators Revised Baseline & Target Setting Form January 1 June 30, Interim Progress Report Overall HIV Indicator A.1: The number of newly diagnosed HIV infections Original
CARE COORDINATION IN NEW YORK CITY
CARE COORDINATION IN NEW YORK CITY Department of Health and Mental Hygiene Bureau of HIV/AIDS Prevention and Control Care and Treatment Unit 1 Funded Programs 28 agencies providing CCP in New York City
A Ministry of the Archdiocese of Galveston-Houston A United Way Agency
A Ministry of the Archdiocese of Galveston-Houston A United Way Agency Integrated Multidsciplinary Approach to Adapt Routine HIV Screening in a Safety Net Clinic Setting Sherri D. Onyiego MD, PhD Baylor
CME Article Hiv Disease Surveillance
CME Article Hiv Disease Surveillance hiv disease surveillance cme Collaboration between Medicine and Public Health Sindy M. Paul, md, mph; Helene Cross, phd; Linda Dimasi, mpa; Abdel R. Ibrahim, phd; and
DC Comprehensive HIV Prevention Plan for 2012-2015: Goals and Objectives
DC Comprehensive HIV Prevention Plan for 2012-2015: Goals and Objectives The Comprehensive Plan includes program goals and objectives, monitoring and evaluation, and capacity building activities specific
Texas Diabetes Fact Sheet
I. Adult Prediabetes Prevalence, 2009 According to the 2009 Behavioral Risk Factor Surveillance System (BRFSS) survey, 984,142 persons aged eighteen years and older in Texas (5.4% of this age group) have
Viral Hepatitis Case Report
Page 1 of 9 Viral Hepatitis Case Report Perinatal Hepatitis B Virus Infection Michigan Department of Community Health Communicable Disease Division Investigation Information Investigation ID Onset Date
Department of Veterans Affairs National HIV/AIDS Strategy Operational Plan 2011
Department of Veterans Affairs National HIV/AIDS Strategy Operational Plan 2011 Table of Contents Purpose..3 Overview of HIV Health Care.....4 Goal 1: Reducing the Number of People who become infected
Using Substance Abuse Prevention and Treatment (SAPT) Block Grant HIV Set- Aside Funds for Integrated Services
Using Substance Abuse Prevention and Treatment (SAPT) Block Grant HIV Set- Aside Funds for Integrated Services ADP Training Conference, Sacramento, August 21, 2012 Rachel McLean, MPH, CA Dept. of Public
2015 State Health Benefit Plan Annual Open Enrollment (OE) Presentation to Active Employees and pre-65 Retirees
2015 State Health Benefit Plan Annual Open Enrollment (OE) Presentation to Active Employees and pre-65 Retirees 0 Mission The Georgia Department of Community Health We will provide access to affordable,
HIV/AIDS Prevention and Care
HIV/AIDS Prevention and Care Nancy S. Padian, PhD, MPH Professor, Obstetrics, Gynecology & Reproductive Sciences Associate Director for Research, Global Health Sciences and AIDS Research Institute: University
2012 Georgia Diabetes Burden Report: An Overview
r-,, 2012 Georgia Diabetes Burden Report: An Overview Background Diabetes and its complications are serious medical conditions disproportionately affecting vulnerable population groups including: aging
FAQs HIV & AIDS. What is HIV? A virus that reduces the effectiveness of your immune system, meaning you are less protected against disease.
HIV & AIDS What is HIV? A virus that reduces the effectiveness of your immune system, meaning you are less protected against disease. What does HIV stand for? Human Immunodeficiency Virus Where did HIV
FEDERAL BUREAU OF PRISONS REPORT ON INFECTIOUS DISEASE MANAGEMENT
FEDERAL BUREAU OF PRISONS REPORT ON INFECTIOUS DISEASE MANAGEMENT What is the purpose of this report? The purpose of this report is to present the administrative policies and clinical guidelines for the
Massachusetts HIV Drug Assistance Program (HDAP) and Comprehensive Health Insurance Initiative (CHII) Application Form
Massachusetts HIV Drug Assistance Program (HDAP) and Comprehensive Health Insurance Initiative (CHII) Application Form Please print clearly and answer all questions. Review the attached instructions before
Likely Female-to-Female Sexual Transmission of HIV Texas, 2012
Morbidity and Mortality Weekly Report (MMWR) Likely Female-to-Female Sexual Transmission of HIV Texas, 2012 Weekly March 14, 2014 / 63(10);209 212 Shirley K. Chan, MPH1, Lupita R. Thornton1, Karen J. Chronister,
GEORGIA DEPARTMENT OF COMMUNITY AFFAIRS OFFICE OF RESEARCH 60 EXECUTIVE PARK SOUTH ATLANTA, GEORGIA 30329-2231 404-679-4940
2007 WAGE AND SALARY SURVEY COMPENSATION OF ELECTED COUNTY OFFICIALS AUGUST 2007 GEORGIA DEPARTMENT OF COMMUNITY AFFAIRS OFFICE OF RESEARCH 60 EXECUTIVE PARK SOUTH ATLANTA, GEORGIA 30329-2231 404-679-4940
HIV/AIDS: General Information & Testing in the Emergency Department
What Is HIV? HIV/AIDS: General Information & Testing in the Emergency Department HIV is the common name for the Human Immunodeficiency Virus. HIV is a retrovirus. This means it can enter the body s own
Hepatitis C Infections in Oregon September 2014
Public Health Division Hepatitis C Infections in Oregon September 214 Chronic HCV in Oregon Since 25, when positive laboratory results for HCV infection became reportable in Oregon, 47,252 persons with
GARPR Online Reporting Tool
GARPR Online Reporting Tool 0 Narrative Report and Cover Sheet 1) Which institutions/entities were responsible for filling out the indicator forms? a) NAC or equivalent Yes b) NAP Yes c) Others Yes If
Antiretroviral therapy for HIV infection in infants and children: Towards universal access
Antiretroviral therapy for HIV infection in infants and children: Towards universal access Executive summary of recommendations Preliminary version for program planning 2010 Executive summary Tremendous
UNITED NATIONS GENERAL ASSEMBLY SPECIAL SESSION ON HIV/AIDS. Country Progress Report 2008. Sweden
UNITED NATIONS GENERAL ASSEMBLY SPECIAL SESSION ON HIV/AIDS Country Progress Report 2008 Sweden ABBREVIATIONS...3 ACKNOWLEDGEMENTS...4 STATUS AT A GLANCE...1 NATIONAL INDICATOR DATA... 2 OVERVIEW OF THE
Meena Abraham, DrPH, MPH Director of Epidemiology Services Baltimore City Health Department
Meena Abraham, DrPH, MPH Director of Epidemiology Services Baltimore City Health Department 271 Neighborhood Statistical Areas 55 Community Statistical Areas 26 Zip Codes Characteristic Baltimore City
Epidemiology of Hepatitis C Infection. Pablo Barreiro Service of Infectious Diseases Hospital Carlos III, Madrid
Epidemiology of Hepatitis C Infection Pablo Barreiro Service of Infectious Diseases Hospital Carlos III, Madrid Worldwide Prevalence of Hepatitis C 10% No data available WHO.
